Inspire Pharmaceuticals Launches AzaSite in the United States for Ocular Infections

Inspire Pharmaceuticals, Inc. announced the U.S. launch and commercial availability of AzaSite (azithromycin ophthalmic solution) 1 percent for the treatment of bacterial conjunctivitis.
Inspire Pharmaceuticals Inc.